ArticleInternational journal of clinical oncology2022

Circulating tumor cells may serve as a supplement to RECIST in neoadjuvant chemotherapy of patients with locally advanced breast cancer.

Ji Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.